Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akynzeo for prevention of postoperative nausea and vomiting after bariatric surgery in adults with morbid obesity
ACTRN12620000455965Phase 4Recruiting
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Feb 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of palonosetron, cyclizine and ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by St Vincent's Hospital Melbourne. Primary endpoints: Overall incidence of nausea and Overall incidence of vomiting. Started Feb 2021; status: recruiting.
02
Drugs
palonosetroncyclizineondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ACTRN12620000455965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000455965.